Cargando…
Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study
Tumor budding has been reported to be an independent prognostic factor in pancreatic ductal adenocarcinoma (PDAC). Its use in daily diagnostics would improve the prognostic stratification of patients. We performed a multicenter interobserver study to test various budding assessment methods for their...
Autores principales: | Karamitopoulou, Eva, Esposito, Irene, Zlobec, Inti, Insilla, Andrea Cacciato, Wartenberg, Martin, Schaeffer, David F., Kalloger, Steve, La Rosa, Stefano, Sempoux, Christine, Ramos Centeno, Irene, Lohneis, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990816/ https://www.ncbi.nlm.nih.gov/pubmed/33330964 http://dx.doi.org/10.1007/s00428-020-02987-2 |
Ejemplares similares
-
Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma
por: Wartenberg, Martin, et al.
Publicado: (2015) -
Tumour budding: a promising parameter in colorectal cancer
por: Lugli, A, et al.
Publicado: (2012) -
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
por: Zlobec, Inti, et al.
Publicado: (2010) -
Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
por: Karamitopoulou, Eva, et al.
Publicado: (2013) -
Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
por: Galván, J A, et al.
Publicado: (2015)